001 | 120062 | ||
005 | 20240228135009.0 | ||
024 | 7 | _ | |a 10.1038/srep04482 |2 doi |
024 | 7 | _ | |a pmid:24670820 |2 pmid |
024 | 7 | _ | |a pmc:PMC5259794 |2 pmc |
024 | 7 | _ | |a altmetric:2216373 |2 altmetric |
037 | _ | _ | |a DKFZ-2017-00649 |
041 | _ | _ | |a eng |
082 | _ | _ | |a 000 |
100 | 1 | _ | |a Olivier, Magali |b 0 |
245 | _ | _ | |a Modelling mutational landscapes of human cancers in vitro. |
260 | _ | _ | |a London |c 2014 |b Nature Publishing Group |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1490777778_9393 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Experimental models that recapitulate mutational landscapes of human cancers are needed to decipher the rapidly expanding data on human somatic mutations. We demonstrate that mutation patterns in immortalised cell lines derived from primary murine embryonic fibroblasts (MEFs) exposed in vitro to carcinogens recapitulate key features of mutational signatures observed in human cancers. In experiments with several cancer-causing agents we obtained high genome-wide concordance between human tumour mutation data and in vitro data with respect to predominant substitution types, strand bias and sequence context. Moreover, we found signature mutations in well-studied human cancer driver genes. To explore endogenous mutagenesis, we used MEFs ectopically expressing activation-induced cytidine deaminase (AID) and observed an excess of AID signature mutations in immortalised cell lines compared to their non-transgenic counterparts. MEF immortalisation is thus a simple and powerful strategy for modelling cancer mutation landscapes that facilitates the interpretation of human tumour genome-wide sequencing data. |
536 | _ | _ | |a 313 - Cancer risk factors and prevention (POF3-313) |0 G:(DE-HGF)POF3-313 |c POF3-313 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
700 | 1 | _ | |a Weninger, Annette |0 P:(DE-He78)b787d22d9cb06342658bf546039117bc |b 1 |u dkfz |
700 | 1 | _ | |a Ardin, Maude |b 2 |
700 | 1 | _ | |a Huskova, Hana |b 3 |
700 | 1 | _ | |a Castells, Xavier |b 4 |
700 | 1 | _ | |a Vallée, Maxime P |b 5 |
700 | 1 | _ | |a McKay, James |b 6 |
700 | 1 | _ | |a Nedelko, Tatiana |0 P:(DE-HGF)0 |b 7 |
700 | 1 | _ | |a Mühlbauer, Karl-Rudolf |0 P:(DE-He78)0a78151e49e9c847ad9e913a5c2b0ffe |b 8 |u dkfz |
700 | 1 | _ | |a Marusawa, Hiroyuki |b 9 |
700 | 1 | _ | |a Alexander, John |b 10 |
700 | 1 | _ | |a Hazelwood, Lee |b 11 |
700 | 1 | _ | |a Byrnes, Graham |b 12 |
700 | 1 | _ | |a Hollstein, Monica |0 P:(DE-He78)f3bec70c95e9e3dce0f39d54b3843118 |b 13 |u dkfz |
700 | 1 | _ | |a Zavadil, Jiri |b 14 |
773 | _ | _ | |a 10.1038/srep04482 |g Vol. 4 |0 PERI:(DE-600)2615211-3 |p 4482 |t Scientific reports |v 4 |y 2014 |x 2045-2322 |
909 | C | O | |o oai:inrepo02.dkfz.de:120062 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)b787d22d9cb06342658bf546039117bc |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)0a78151e49e9c847ad9e913a5c2b0ffe |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-He78)f3bec70c95e9e3dce0f39d54b3843118 |
913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-313 |2 G:(DE-HGF)POF3-300 |v Cancer risk factors and prevention |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
914 | 1 | _ | |y 2014 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b SCI REP-UK : 2015 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |
915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1150 |2 StatID |b Current Contents - Physical, Chemical and Earth Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b SCI REP-UK : 2015 |
920 | 1 | _ | |0 I:(DE-He78)C016-20160331 |k C016 |l Genetische Veränderungen bei der Karzinogenese |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)C016-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|